First AD

Second AD

Specialists’ Individual Treatment Plans for Patients With FCS: PCP

Video content above is prompted by the following:

Please share your management approach and unique considerations for patients with FCS as a/an [endocrinologist / cardiologist / internist / pancreatic specialist]?

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Treatment of Familial Chylomicronemia Syndrome: A Multidisciplinary Approach

Familial chylomicronemia syndrome (FCS) is a rare genetic disorder characterized by extremely high triglyceride levels, leading to recurrent pancreatitis and other complications. Delayed diagnosis and treatment can exacerbate cardiovascular and metabolic consequences, including increased risk of atherosclerosis, cardiovascular disease, and metabolic syndrome. Long-term health risks involve persistent hypertriglyceridemia, which can cause chronic pancreatitis, diabetes, and liver disease. Early intervention is crucial to mitigate these risks, improve patient outcomes, and enhance quality of life by managing triglyceride levels and preventing severe complications.

Panelists discuss their management approaches and unique considerations for patients with familial chylomicronemia syndrome (FCS) from the perspectives of endocrinologists, cardiologists, internists, and pancreatic specialists, highlighting specialized treatment strategies and collaborative care.

Overview of FCS

Severe Hypertriglyceridemia